Tags

Type your tag names separated by a space and hit enter

[Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome].
Zentralbl Chir. 2005 Jun; 130(3):246-9.ZC

Abstract

The transjugular intrahepatic portosystemic stent shunt has replaced surgical shunt procedures as the standard therapy for complications of portal hypertension such as refractory ascites and recurrent variceal bleeding. However, reinterventions due to TIPS stenosis are necessary in 25-50 %. Major complications are the manifestation or worsening of hepatic encephalopathy. Recent studies using PTFE covered stents have shown lower stenosis rates and a trend towards prolonged survival.

Links

Publisher Full Text

Authors+Show Affiliations

Wettstein M
Gastroenterologie, Universitätsklinikum Düsseldorf. wettstein@med.uni-duesseldorf.de
Lüthen R
No affiliation info available
Cohnen M
No affiliation info available
von Wrisberg F
No affiliation info available
Mödder U
No affiliation info available
Häussinger D
No affiliation info available

MeSH

AscitesEsophageal and Gastric VaricesGastrointestinal HemorrhageHumansHypertension, PortalPortasystemic Shunt, Transjugular IntrahepaticRecurrenceTreatment Outcome

Pub Type(s)

English Abstract
Journal Article
Review

Language

ger

PubMed ID

15965878

Citation

Wettstein, M, et al. "[Transjugular Intrahepatic Portosystemic Stent Shunt: Indications and Long-term Outcome]." Zentralblatt Fur Chirurgie, vol. 130, no. 3, 2005, pp. 246-9.
Wettstein M, Lüthen R, Cohnen M, et al. [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome]. Zentralbl Chir. 2005;130(3):246-9.
Wettstein, M., Lüthen, R., Cohnen, M., von Wrisberg, F., Mödder, U., & Häussinger, D. (2005). [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome]. Zentralblatt Fur Chirurgie, 130(3), 246-9.
Wettstein M, et al. [Transjugular Intrahepatic Portosystemic Stent Shunt: Indications and Long-term Outcome]. Zentralbl Chir. 2005;130(3):246-9. PubMed PMID: 15965878.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Transjugular intrahepatic portosystemic stent shunt: indications and long-term outcome]. AU - Wettstein,M, AU - Lüthen,R, AU - Cohnen,M, AU - von Wrisberg,F, AU - Mödder,U, AU - Häussinger,D, PY - 2005/6/21/pubmed PY - 2005/11/11/medline PY - 2005/6/21/entrez SP - 246 EP - 9 JF - Zentralblatt fur Chirurgie JO - Zentralbl Chir VL - 130 IS - 3 N2 - The transjugular intrahepatic portosystemic stent shunt has replaced surgical shunt procedures as the standard therapy for complications of portal hypertension such as refractory ascites and recurrent variceal bleeding. However, reinterventions due to TIPS stenosis are necessary in 25-50 %. Major complications are the manifestation or worsening of hepatic encephalopathy. Recent studies using PTFE covered stents have shown lower stenosis rates and a trend towards prolonged survival. SN - 0044-409X UR - https://www.unboundmedicine.com/medline/citation/15965878/[Transjugular_intrahepatic_portosystemic_stent_shunt:_indications_and_long_term_outcome]_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-2005-836547 DB - PRIME DP - Unbound Medicine ER -